B. von Graffenried

1.3k total citations · 1 hit paper
20 papers, 945 citations indexed

About

B. von Graffenried is a scholar working on Surgery, Pharmacology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, B. von Graffenried has authored 20 papers receiving a total of 945 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 5 papers in Pharmacology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in B. von Graffenried's work include Pain Mechanisms and Treatments (3 papers), Diabetes and associated disorders (3 papers) and Pancreatic function and diabetes (3 papers). B. von Graffenried is often cited by papers focused on Pain Mechanisms and Treatments (3 papers), Diabetes and associated disorders (3 papers) and Pancreatic function and diabetes (3 papers). B. von Graffenried collaborates with scholars based in Japan, Canada and Australia. B. von Graffenried's co-authors include John Dupré, C. R. Stiller, N. W. Rodger, Paul Keown, B. M. Wolfe, M. Jenner, R. Martell, Andreas Laupacis, Michael Gent and G Feutren and has published in prestigious journals such as Nature, Science and The Lancet.

In The Last Decade

B. von Graffenried

20 papers receiving 860 citations

Hit Papers

Effects of Cyclosporine I... 1984 2026 1998 2012 1984 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. von Graffenried Japan 12 369 358 348 176 144 20 945
Adina Zeidler United States 22 615 1.7× 647 1.8× 655 1.9× 242 1.4× 181 1.3× 51 1.5k
Urs Zumsteg Switzerland 15 334 0.9× 286 0.8× 216 0.6× 278 1.6× 169 1.2× 35 910
Junji Takeyama Japan 21 358 1.0× 214 0.6× 375 1.1× 113 0.6× 261 1.8× 41 1.4k
Alan N. Elias United States 17 97 0.3× 132 0.4× 276 0.8× 62 0.4× 146 1.0× 61 791
José Rodrı́guez-Espinosa Spain 18 114 0.3× 299 0.8× 512 1.5× 30 0.2× 150 1.0× 55 1.2k
L. Kerp Germany 15 135 0.4× 174 0.5× 294 0.8× 45 0.3× 217 1.5× 81 799
L. M. Demers United States 22 253 0.7× 89 0.2× 427 1.2× 50 0.3× 353 2.5× 30 1.4k
Mary L. Voorhess United States 24 158 0.4× 279 0.8× 418 1.2× 25 0.1× 191 1.3× 59 1.4k
Eero Lindholm Sweden 21 479 1.3× 355 1.0× 480 1.4× 110 0.6× 334 2.3× 27 1.4k
Şazi İmamoğlu Türkiye 16 269 0.7× 118 0.3× 421 1.2× 58 0.3× 434 3.0× 48 1.5k

Countries citing papers authored by B. von Graffenried

Since Specialization
Citations

This map shows the geographic impact of B. von Graffenried's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. von Graffenried with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. von Graffenried more than expected).

Fields of papers citing papers by B. von Graffenried

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. von Graffenried. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. von Graffenried. The network helps show where B. von Graffenried may publish in the future.

Co-authorship network of co-authors of B. von Graffenried

This figure shows the co-authorship network connecting the top 25 collaborators of B. von Graffenried. A scholar is included among the top collaborators of B. von Graffenried based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. von Graffenried. B. von Graffenried is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Feutren, G & B. von Graffenried. (1992). Pharmacology and Therapeutic Use in Autoimmune Diseases. 2 indexed citations
2.
Schernthaner, Guntram, Jørn Nerup, F. A. Gries, et al.. (1991). Follow-up of cyclosporin A treatment in Type 1 (insulin-dependent) diabetes mellitus: lack of long-term effects. Diabetologia. 34(6). 429–434. 46 indexed citations
3.
Graffenried, B. von, G Feutren, W A Schiess, et al.. (1991). Safety and tolerability of cyclosporin A (Sandimmun®) in idiopathic nephrotic syndrome. Clinical Nephrology. 35. 12 indexed citations
4.
Feutren, G & B. von Graffenried. (1991). Pharmacology of cyclosporin A (Sandimmun) and clinical experience in inflammatory bowel diseases.. PubMed. 121(20). 748–53. 10 indexed citations
5.
Friend, David R., et al.. (1990). Efficacy of low-dose cyclosporin A in psoriasis: results of dose-finding studies. British Journal of Dermatology. 122(s36). 33–39. 64 indexed citations
6.
Feutren, G, Kamal Abeywickrama, David R. Friend, & B. von Graffenried. (1990). Renal function and blood pressure in psoriatic patients treated with cyclosporin A. British Journal of Dermatology. 122(s36). 57–69. 53 indexed citations
7.
Graffenried, B. von, et al.. (1988). Ciclosporin in Rheumatoid Arthritis: A Review. Birkhäuser Basel eBooks. 24. 236–253. 4 indexed citations
8.
Mandrup‐Poulsen, Thomas, C. R. Stiller, Giuseppe Billè, et al.. (1985). DISAPPEARANCE AND REAPPEARANCE OF ISLET CELL CYTOPLASMIC ANTIBODIES IN CYCLOSPORIN-TREATED INSULIN-DEPENDENT DIABETICS. The Lancet. 325(8429). 599–602. 36 indexed citations
9.
Stiller, C. R., John Dupré, Michael Gent, et al.. (1984). Effects of Cyclosporine Immunosuppression in Insulin-Dependent Diabetes Mellitus of Recent Onset. Science. 223(4643). 1362–1367. 428 indexed citations breakdown →
10.
Robson, Scott A., et al.. (1984). Pharmacokinetic study of cyclosporin A (Sandimmun) in patients with primary biliary cirrhosis.. British Journal of Clinical Pharmacology. 18(4). 627–631. 18 indexed citations
11.
Marti, Hanna, et al.. (1981). Antipyretic activity of fluproquazone in man.. PubMed. 31(5a). 934–5. 5 indexed citations
12.
Graffenried, B. von, et al.. (1980). Assessment of analgesics in dental surgery outpatients. European Journal of Clinical Pharmacology. 18(6). 479–482. 19 indexed citations
13.
Herrmann, Ulrich, et al.. (1980). Analgesie effect of fluproquazone in postoperative patients. Clinical Pharmacology & Therapeutics. 27(3). 379–385. 5 indexed citations
14.
Graffenried, B. von & E. Nüesch. (1980). Non‐migrainous headache for the evaluation of oral analgesics.. British Journal of Clinical Pharmacology. 10(S2). 225S–231S. 20 indexed citations
15.
Pozo, Emilio del, et al.. (1980). Endocrine Effect of a Methionine-Enkephalin Derivative (FK 33-824) in Man. Hormone Research. 13(2). 90–97. 31 indexed citations
16.
Graffenried, B. von, Ronald C. Hill, & E. Nüesch. (1980). Headache As a Model for Assessing Mild Analgesic Drugs. The Journal of Clinical Pharmacology. 20(2-3). 131–144. 11 indexed citations
17.
Graffenried, B. von. (1978). Effets compétitifs du pindolol et du salbutamol sur la résistance des voies aériennes chez les asthmatiques.. ˜La œNouvelle presse médicale. 7(31). 2 indexed citations
18.
Graffenried, B. von, et al.. (1978). Headache as a Model for Testing Mild Analgesics. PubMed. 6. 103–109. 2 indexed citations
19.
Graffenried, B. von, et al.. (1978). Effects of the synthetic enkephalin analogue FK 33-824 in man. Nature. 272(5655). 729–730. 117 indexed citations
20.
Graffenried, B. von, Rolf Adler, Klaus Abt, E. Nüesch, & René Spiegel. (1977). The influence of anxiety and pain sensitivity on experimental pain in man. Pain. 4(Supp C). 253–263. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026